ABSTRACT
Thromboembolism is a well-recognized complication of malignant disease. Clinical
manifestations vary from venous thromboembolism (VTE) to disseminated intravascular
coagulation, more commonly observed in patients with haematological malignancies and
those with widespread metastatic cancer, to arterial embolism, more commonly observed
in patients undergoing chemotherapy and in those with non-bacterial thrombotic endo-
carditis. This overview will focus on the relationship between cancer and VTE.
